Using tissue from mouse embryos, researchers prepared brain cultures using conditions that favor the slowly progressing loss of dopamine neurons, a hallmark of the disease.

Often patients are given prescriptions for levodopa, or L-dopa, which is converted into dopamine by enzymes in the brain.

Low dose levodopa and dopamine agonists are effective in controlling most symptoms of the disorder.